Leg-up at Smith & Nephew
The global economy must be on the up: people are buying more artificial knees and hips.
Smith & Nephew, Europe's biggest supplier of replacement joints, which suffered in the recession as patients were too scared to take time off work for operations, saw 2011 revenues rise 4 per cent to $4.3bn (£2.7bn).
But the company's pre-tax profit was 4 per cent lower at $961m.
It is planning to cut 7 per cent of its 11,000 worldwide workforce over the next three years.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies